Porcilis® Ery + Parvo
Porcilis Ery+Parvo is an inactivated vaccine containing at least 1 ppd Erysipelothrix rhusiopathiae antigen and Porcine parvovirus (PPV) in an aqueous white or nearly white suspension.
Presentation
Suspension for injection
Active ingredients
Per dose:
- Inactivated lysed antigen concentrate of Erysipelothrix rhusiopathiae strain M2 (serotype 2): ≥ 1 pig protective dose (ppd)*
- Inactivated porcine parvovirus (PPV) strain 014: ≥ 552 EU**
* as measured in the Ph. Eur. potency test
** as determined in the final product by antigenic mass ELISA
Target species
Pigs (sows and gilts)
Indications for use
For active immunisation of sows and gilts to prevent clinical signs of Erysipelas disease caused by all relevant Erysipelothrix rhusiopathiae serotypes (serotype 1 and 2) and for protection against embryonal and foetal death caused by porcine parvovirus (PPV) infection.
Withdrawal periods
Pigs – meat: zero days
Packaging
PET - vial closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
Pack sizes:
1 vial of 20 ml (10 doses), 50 ml (25 doses), 100 ml (50 doses) or 250 ml (125 doses) packed in a cardboard box.
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025